Literature DB >> 3190198

Effects of cyclophosphamide and a metabolite, acrolein, on Naegleria fowleri in vitro and in vivo.

L Zhang1, F Marciano-Cabral, S G Bradley.   

Abstract

Mice challenged intranasally with Naegleria fowleri died of primary amoebic meningoencephalitis. Mice given 30 mg of cyclophosphamide per kg of body weight daily for 10 days starting 2 days before challenge were protected. Neither cyclophosphamide nor serum from cyclophosphamide-treated mice inhibited N. fowleri in vitro. A metabolic product of cyclophosphamide, acrolein, inhibited growth and enflagellation of N. fowleri. Acrolein at 40 microM was amoebicidal. Acrolein injured starved cells and amoebae at 5 degrees C and growing N. fowleri.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3190198      PMCID: PMC172325          DOI: 10.1128/AAC.32.7.962

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Enhancement of delayed hypersensitivity by depletion of suppressor T cells with cyclophosphamide in mice.

Authors:  A Mitsuoka; M Baba; S Morikawa
Journal:  Nature       Date:  1976-07-01       Impact factor: 49.962

2.  Isolation and identification of a stabilized derivative of aldophosphamide, a major metabolite of cyclophosphamide.

Authors:  R F Struck
Journal:  Cancer Res       Date:  1974-11       Impact factor: 12.701

3.  Reversal of immunological tolerance by cyclophosphamide through inhibition of suppressor cell activity.

Authors:  L Polak; J L Turk
Journal:  Nature       Date:  1974-06-14       Impact factor: 49.962

4.  Suppressor cells in normal immunisation as a basic homeostatic phenomenon.

Authors:  S I Katz; D Parker; G Sommer; J L Turk
Journal:  Nature       Date:  1974-04-12       Impact factor: 49.962

5.  Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide.

Authors:  T A Connors; P J Cox; P B Farmer; A B Foster; M Jarman
Journal:  Biochem Pharmacol       Date:  1974-01-01       Impact factor: 5.858

6.  A biologically active metabolite of cyclophosphamide.

Authors:  M Colvin; C A Padgett; C Fenselau
Journal:  Cancer Res       Date:  1973-04       Impact factor: 12.701

7.  Enhancement of dinitrochlorobenzene (DNCB) contact sensitization by cyclophosphamide in the guinea pig.

Authors:  H C Maguire; V L Ettore
Journal:  J Invest Dermatol       Date:  1967-01       Impact factor: 8.551

8.  Enhancement of in vivo and in vitro murine immune responses by the cyclophosphamide metabolite acrolein.

Authors:  T T Kawabata; K L White
Journal:  Cancer Res       Date:  1988-01-01       Impact factor: 12.701

9.  Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide.

Authors:  P H Lagrange; G B Mackaness; T E Miller
Journal:  J Exp Med       Date:  1974-06-01       Impact factor: 14.307

10.  Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses.

Authors:  P W Askenase; B J Hayden; R K Gershon
Journal:  J Exp Med       Date:  1975-03-01       Impact factor: 14.307

View more
  2 in total

1.  Naegleria fowleri after 50 years: is it a neglected pathogen?

Authors:  Moisés Martínez-Castillo; Roberto Cárdenas-Zúñiga; Daniel Coronado-Velázquez; Anjan Debnath; Jesús Serrano-Luna; Mineko Shibayama
Journal:  J Med Microbiol       Date:  2016-07-04       Impact factor: 2.472

2.  Efficient Liquid Media for Encystation of Pathogenic Free-Living Amoebae.

Authors:  Hae-Jin Sohn; Heekyoung Kang; Ga-Eun Seo; Jong-Hyun Kim; Suk-Yul Jung; Ho-Joon Shin
Journal:  Korean J Parasitol       Date:  2017-06-30       Impact factor: 1.341

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.